In the News – Bimatoprost Scalp Failed to Provide Sufficient Efficacy

Snippet from the article:

A mid-stage trial of Allergan’s hair loss treatment Bimatoprost Scalp also failed to provide sufficient efficacy to proceed to a late-stage study, and the company said it will be extending the mid-stage development program.

Link: Allergan delays eye drug, shares fall

I found the above tidbit buried within an article about Allergan’s delay of their eye drug to treat age-related macular degeneration. Many folks were hoping bimatoprost (the eyelash treatment also known as Latisse) used on the scalp would be the next FDA approved hair loss treatment, but it seems that will be delayed for some time.